Noticias de LIFE_US

Noticias del mercado

Últimas noticias sobre LIFE_US — 44 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LIFE_US ✕ 44 resultados
21/04/2026 LIFE_US — Xã Thanh Hà
What is the growth outlook for aTyr Pharma (ATYR) stock (Range-Bound) 2026-04-20 - Entry Points
21/04/2026 LIFE_US — sonla.gov.vn
What is the growth outlook for aTyr Pharma (ATYR) stock (Range-Bound) 2026-04-20 - Breakout Watch
21/04/2026 LIFE_US — haiphong.gov.vn
What is the growth outlook for aTyr Pharma (ATYR) stock (Range-Bound) 2026-04-20 - Entry Points
21/04/2026 LIFE_US — AD HOC NEWS
aTyr Pharma Inc stock (US53227K1025): Is efzofitimod's Phase 3 data the real test for pulmonary sarc
20/04/2026 LIFE_US — sonla.gov.vn
aTyr Pharma (ATYR) Stock: This Quarter (Near Highs) 2026-04-20 - Community Chart Signals
20/04/2026 LIFE_US — syt.laocai.gov.vn ES ← EN
Acciones de aTyr Pharma (ATYR): este trimestre (cerca de máximos) 2026-04-20 - Señales de continuación
20/04/2026 LIFE_US — laocai.gov.vn
aTyr Pharma (ATYR) Stock: This Quarter (Near Highs) 2026-04-20 - Community Chart Signals
20/04/2026 LIFE_US — vinhcong.tayninh.gov.vn ES ← EN
Acciones de aTyr Pharma (ATYR): este trimestre (cerca de máximos) 2026-04-20 - Señales de gráficos comunitarios
18/04/2026 LIFE_US — laocai.gov.vn ES ← EN
Comercio de materias primas en acciones de aTyr Pharma (ATYR) (los inversores se acumulan) 2026-04-18 - Selecciones de impulso compartido
15/04/2026 LIFE_US — vinhcong.tayninh.gov.vn ES ← EN
Acciones de aTyr Pharma (ATYR): ¿sobrevaloradas? (Toca alto) 2026-04-15 - Potencial de ganancias
15/04/2026 LIFE_US — laocai.gov.vn
aTyr Pharma (ATYR) Stock: Overpriced? (Touches High) 2026-04-15 - Social Trading Insights
15/04/2026 LIFE_US — haiphong.gov.vn
aTyr Pharma (ATYR) Stock: Overpriced? (Touches High) 2026-04-15 - Profit Potential
09/04/2026 LIFE_US — Xã Châu Thành
Can aTyr Pharma (ATYR) Stock increase dividends | Price at $0.77, Down 3.64% - Target Price
09/04/2026 LIFE_US — haiphong.gov.vn
Can aTyr Pharma (ATYR) Stock increase dividends | Price at $0.77, Down 3.64% - Most Discussed Stocks
26/03/2026 LIFE_US — Stock Titan
aTyr Pharma (NASDAQ: ATYR) seeks approval to double share authorization
26/03/2026 LIFE_US — Stock Titan
Vanguard disaggregates holdings; reports 0 shares in aTyr Pharma (ATYR)
26/03/2026 LIFE_US — Stock Titan ES ← EN
[ARS] Presentación ante la SEC de aTYR PHARMA INC
12/03/2026 LIFE_US — Yahoo Finance
aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting
11/03/2026 LIFE_US — TradingView
ATYR: Efzofitimod shows durable quality of life gains and is reshaping sarcoidosis treatment practices
10/03/2026 LIFE_US — openPR.com
Investigation announced for Long-Term Investors in shares

Página 1 de 3

keyboard_arrow_up